Lesaka continues strong growth trajectory and achieves upper end of revenue guidance

Loading player...
GUEST - Lincoln Mali CEO Lesaka Southern Africa

Technology and financial services group Lesaka Technologies narrowed its net loss by 42% in three months ended September, boosted in part by its fintech business while cost-cutting initiatives in the consumer segment also paid off.

Lesaka, which has a primary listing on Nasdaq and secondary listing on the JSE, provides informal retail merchants with a point-of-sale device with which they can pay their suppliers and sell many products, including airtime and electricity. More than 72,000 informal retail merchants use its cash management solutions, bill payment technologies, value-added services, business funding and card acquiring solutions. It also provides unsecured credit, transactional banking and microinsurance to customers through its EasyPay Everywhere brand.

Group revenue rose 19% to R2.5bn year on year, driven by an increase in low-margin prepaid airtime sales and other value-added services, as well as higher transaction, insurance and lending revenues
8 Nov 2023 3PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min